If you liked this article you might like

2 Small-Cap Biotech Buyout Targets
Get Excited About Incyte
Hey Gilead, Stop Developing Drugs and Start Buying Biotech Companies -- Now!
Six Thoughts on President Trump and the Durability of the Biotech Stock Rally